Nautilus Biotechnology, Inc. (NAUT)
↓ Download CSVKey ratios (FY2025)
-37.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Net Income | -$59.00M | -$70.78M | -$63.67M | -$57.92M | -$50.31M | -$15.62M | — |
| EPS (Diluted) | $-0.47 | $-0.56 | $-0.51 | $-0.46 | $-0.60 | $-0.54 | — |
| Total Assets | $191.11M | $242.74M | $305.56M | $350.05M | $398.45M | $85.01M | — |
| Total Liabilities | $34.14M | $34.01M | $40.21M | $35.13M | $34.87M | $6.31M | — |
| Shareholders' Equity | $156.97M | $208.73M | $265.35M | $314.92M | $363.58M | -$29.72M | -$14.51M |
| Cash & Equivalents | $12.39M | $27.65M | $19.40M | $114.52M | $185.62M | $36.61M | — |
| Operating Cash Flow | -$50.70M | -$59.15M | -$51.71M | -$45.81M | -$39.24M | -$14.00M | — |
| Capital Expenditures | $1.28M | $2.12M | $2.44M | $2.32M | $2.27M | $921.0K | — |
| Shares Outstanding | 126.47M | 126.11M | 125.07M | 124.87M | 124.30M | 33.07M | — |